Palo Alto-based company Midi Health has successfully raised $100 million in a Series D funding round, elevating its valuation to over $1 billion. The funding was led by Goodwater Capital, with participation from new investors Foresite Capital and Serena Ventures. Existing supporters, including GV, Emerson Collective, SemperVirens, McKesson Ventures, Advance Venture Partners, and Felicis Ventures, also contributed to this significant investment.
The funding comes at a time when Midi Health aims to address substantial gaps in women’s healthcare, especially as approximately two million women in the United States enter menopause annually. The economic burden of untreated symptoms is estimated to cost billions in healthcare expenses and lost productivity. According to Joanna Strober, co-founder and CEO of Midi Health, this funding serves as validation for their mission to improve healthcare for women. “Women’s health has been treated like an afterthought for too long. This funding gives us the resources to rewrite that story at scale,” she stated.
Innovative AI-Driven Solutions for Women’s Health
Founded to provide accessible, insurance-covered healthcare services, Midi Health operates across all 50 states. The company leverages an AI engine to enhance its services in three critical areas: personalizing patient experiences, streamlining operational efficiency, and improving health outcomes.
The AI-powered chart analysis tailors each patient’s healthcare journey, supporting quicker and more accurate diagnoses and management. Additionally, automation in scheduling, triage, and documentation improves overall operational efficiency. With one of the largest datasets in women’s health, the company’s AI also helps refine clinical protocols and enhance treatment outcomes.
Currently, Midi Health collaborates with insurers covering over 45 million women in the United States. Each week, more than 25,000 patients use the platform for coordinated care that spans various specialties, including OB-GYN, internal medicine, cardiology, endocrinology, survivorship, obesity, sleep, mood disorders, and dermatology.
Demonstrated Impact on Patient Care
Midi Health reports that its innovative care model is beginning to show tangible results. The company has observed increased adherence to cancer screenings and lower overall healthcare costs compared to similar patient groups. Furthermore, improvements in key health metrics such as A1c and LDL levels have been noted.
By employing AI to assist in clinical decision-making and to personalize each patient’s care journey, Midi Health is working to reduce the administrative burden on healthcare providers. This strategic approach not only enhances patient experiences but also aims to promote better health outcomes over time.
As the company continues to grow, the recent funding aligns with its commitment to transforming the landscape of women’s healthcare, ensuring that it receives the attention and resources it deserves.
